The Coalition for Pulmonary Fibrosis (CPF) recently published an overview of the most important 2014 developments regarding the research…
Articles by Patrícia Silva, PhD
The Canadian Pulmonary Fibrosis Foundation has listed a series of clinical trials on their website that are currently enrolling patients…
The Scleroderma Research Foundation will host a free, live webinar on the relationship between pulmonary fibrosis (PF) and scleroderma on Thursday,…
The chief executive officer and president of Pacific Therapeutics, a clinical stage specialty pharmaceutical company…
The National Institutes of Health (NIH) recently granted a $15.6 million award to The University of North Carolina,…
The companies Bristol-Myers Squibb and Galecto Biotech AB have signed an agreement giving Bristol the exclusive option…
Ofev (nintedanib) capsules, a new drug treatment for idiopathic pulmonary fibrosis (IPF) developed by…
The United States just received the first two treatments for idiopathic pulmonary fibrosis, however, while …
The U.S. Food and Drug Administration (FDA) recently approved two drugs that are the first therapies specifically directed…
Seo Hyo-seok, a specialist in Korean traditional medicine, is visiting the United States for a week to promote his…